CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,208,275
- in 16 filings, $12.2M under 10b5-1 plans
Net −$12,208,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-11 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −2,366 | $53.03 | $125K | 135,004 |
| 2024-06-11 | Malik Fady Ibraham EVP Research & Development | Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −5,422 | 68,900 | ||
| 2024-06-10 | Bhanji Muna Director | Sale 10b5-1 | −2,000 | $52.07 | $104K | 17,631 |
| 2024-06-04 | Blum Robert I President & CEO | Sale 10b5-1 | −22,500 | $48.85 | $1.1M | 439,145 |
| 2024-06-03 | Harrington Robert Arthur Director | Sale 10b5-1 | −1,580 | $48.64 | $77K | 15,541 |
| 2024-06-03 | PARSHALL B LYNNE Director | Option exercise 10b5-1 | +5,000 | $10.68 | $53K | 20,600 |
| 2024-06-03 | PARSHALL B LYNNE Director | Sale 10b5-1 | −5,000 | $48.64 | $243K | 15,600 |
| 2024-06-03 | PARSHALL B LYNNE Director | Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −5,000 | 15,000 | ||
| 2024-06-03 | Wong Robert VP, Chief Accounting Officer | Sale 10b5-1 | −13,011 | $48.88 | $636K | 16,653 |
| 2024-05-31 | Lee Sung EVP, Chief Financial Officer | Grant or award | +34,684 | 34,684 | ||
| 2024-05-31 | Lee Sung EVP, Chief Financial Officer | Grant or award · Non-Qualified Stock Option (Right to Buy) | +53,417 | 53,417 | ||
| 2024-05-15 | Bhanji Muna Director | Grant or award | +5,600 | 19,631 | ||
| 2024-05-15 | Bhanji Muna Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +3,636 | 3,636 | ||
| 2024-05-15 | COSTA SANTO J Director | Grant or award | +5,600 | 20,600 | ||
| 2024-05-15 | COSTA SANTO J Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +3,636 | 3,636 | ||
| 2024-05-15 | Harrington Robert Arthur Director | Grant or award | +5,600 | 17,121 | ||
| 2024-05-15 | Harrington Robert Arthur Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +3,636 | 3,636 | ||
| 2024-05-15 | HENDERSON JOHN T Director | Grant or award | +5,600 | 37,670 | ||
| 2024-05-15 | HENDERSON JOHN T Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +3,636 | 3,636 | ||
| 2024-05-15 | Kaye Edward M. MD Director | Grant or award | +5,600 | 24,917 |
Page 32 of 33 · 660 trades